Piyakorn Boonyoung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Piyakorn Boonyoung has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abdi Wira Septama
Research Center for Pharmaceutical Ingredient and Traditional Medicine, National Research and Innovation Agency (BRIN), KST Soekarno, Cibinong, Jawa Barat, 16911, Indonesia
1 shared publication - Arisara Phuwajaroanpong
Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80160, Thailand
1 shared publication - Atthaphon Konyanee
Center of Excellence in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat 80160, Thailand
1 shared publication - Chuchard Punsawad
Center of Excellence in Tropical Pathobiology, Walailak University, Nakhon Si Thammarat 80160, Thailand
1 shared publication - Farid Saleh
Departments of Anatomy and Medical Education, College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University, Al-Nada, Kingdom of Saudi Arabia
1 shared publication - Ibrahim Sayoh
Faculty of Science and Technology, Princess of Naradhiwas University, Narathiwat, 96000, Thailand
1 shared publication
Latest Publications
- Open Access
In Vitro and In Vivo Antiplasmodial Activities, Phytochemical Characterization, and Acute Oral Toxicity of Leaf Extracts of Blumea balsamifera
Blumea balsamifera is traditionally used in Thai herbal remedies for fever management; however, its antiplasmodial potential has not been comprehensively investigated. In this study, we evaluated the in vitro and in vivo antiplasmodial activities, phytochemical profile, and acute oral toxicity of B. balsamifera leaf extracts. Antiplasmodial activity against Plasmodium falciparum K1 and cytotoxicity against Vero cells were determined using the parasite lactate dehydrogenase (pLDH) assay and an MTT assay, respectively. Phytochemical constituents of the ethanolic extract were characterized by liquid chromatography–quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). In vivo antiplasmodial assessment was investigated in Plasmodium berghei ANKA-infected mice using Peters’ four-day suppressive test at oral doses of 200, 400, and 600 mg/kg. Acute oral toxicity was evaluated following a single oral dose of 2000 mg/kg. The ethanolic extract exhibited promising in vitro antiplasmodial activity, with an IC50 value of 2.65 µg/mL and a selectivity index (SI) of 23.03, whereas the aqueous extract was inactive (IC50 > 40 µg/mL). LC-QTOF-MS analysis of the ethanolic leaf extract tentatively identified 16 compounds in the negative ionization mode and 30 compounds in the positive ionization mode. In the four-day suppressive test, the ethanolic extract demonstrated dose-dependent antiplasmodial activity, with parasitemia suppression of 42.29%, 70.74%, and 76.54% at doses of 200, 400, and 600 mg/kg, respectively. In the acute toxicity study, no mortality, abnormal clinical signs, or significant changes in body weight, food consumption, or water intake were observed. Furthermore, no evidence of hepatotoxicity or nephrotoxicity was detected. The ethanolic leaf extract of B. balsamifera demonstrated antiplasmodial activity in both in vitro and in vivo models, with favorable selectivity and no apparent acute toxicity at the tested dose. These findings support the potential of B. balsamifera as a source of antiplasmodial compounds and provide a basis for further phytochemical isolation and mechanistic studies.
Open AccessIn Vitro and In Vivo Antiplasmodial Activities, Phytochemical Characterization, and Acute Oral Toxicity of Leaf Extracts of Blumea balsamifera
Blumea balsamifera is traditionally used in Thai herbal remedies for fever management; however, its antiplasmodial potential has not been comprehensively investigated. In this study, we evaluated the in vitro and in vivo antiplasmodial activities, phytochemical profile, and acute oral toxicity of B. balsamifera leaf extracts. Antiplasmodial activity against Plasmodium falciparum K1 and cytotoxicity against Vero cells were determined using the parasite lactate dehydrogenase (pLDH) assay and an MTT assay, respectively. Phytochemical constituents of the ethanolic extract were characterized by liquid chromatography–quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). In vivo antiplasmodial assessment was investigated in Plasmodium berghei ANKA-infected mice using Peters’ four-day suppressive test at oral doses of 200, 400, and 600 mg/kg. Acute oral toxicity was evaluated following a single oral dose of 2000 mg/kg. The ethanolic extract exhibited promising in vitro antiplasmodial activity, with an IC50 value of 2.65 µg/mL and a selectivity index (SI) of 23.03, whereas the aqueous extract was inactive (IC50 > 40 µg/mL). LC-QTOF-MS analysis of the ethanolic leaf extract tentatively identified 16 compounds in the negative ionization mode and 30 compounds in the positive ionization mode. In the four-day suppressive test, the ethanolic extract demonstrated dose-dependent antiplasmodial activity, with parasitemia suppression of 42.29%, 70.74%, and 76.54% at doses of 200, 400, and 600 mg/kg, respectively. In the acute toxicity study, no mortality, abnormal clinical signs, or significant changes in body weight, food consumption, or water intake were observed. Furthermore, no evidence of hepatotoxicity or nephrotoxicity was detected. The ethanolic leaf extract of B. balsamifera demonstrated antiplasmodial activity in both in vitro and in vivo models, with favorable selectivity and no apparent acute toxicity at the tested dose. These findings support the potential of B. balsamifera as a source of antiplasmodial compounds and provide a basis for further phytochemical isolation and mechanistic studies.
- Open Access
- 12 December 2012
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 252
Young coconut juice can accelerate the healing process of cutaneous wounds
Estrogen has been reported to accelerate cutaneous wound healing. This research studies the effect of young coconut juice (YCJ), presumably containing estrogen-like substances, on cutaneous wound healing in ovairectomized rats.
- 12 December 2012
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 252
Open AccessYoung coconut juice can accelerate the healing process of cutaneous wounds
Estrogen has been reported to accelerate cutaneous wound healing. This research studies the effect of young coconut juice (YCJ), presumably containing estrogen-like substances, on cutaneous wound healing in ovairectomized rats.